Ruffer LLP Takes $10.27 Million Position in Maximus, Inc. (NYSE:MMS)

Ruffer LLP acquired a new stake in Maximus, Inc. (NYSE:MMS - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 137,517 shares of the health services provider's stock, valued at approximately $10,266,000. Ruffer LLP owned 0.24% of Maximus as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Robeco Institutional Asset Management B.V. boosted its stake in Maximus by 32.8% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 17,635 shares of the health services provider's stock valued at $1,643,000 after purchasing an additional 4,354 shares during the period. QRG Capital Management Inc. raised its stake in Maximus by 31.9% in the 3rd quarter. QRG Capital Management Inc. now owns 4,336 shares of the health services provider's stock worth $404,000 after purchasing an additional 1,048 shares in the last quarter. Atria Investments Inc acquired a new stake in Maximus in the 3rd quarter worth about $244,000. Covestor Ltd grew its position in shares of Maximus by 913.0% during the 3rd quarter. Covestor Ltd now owns 1,246 shares of the health services provider's stock worth $116,000 after purchasing an additional 1,123 shares in the last quarter. Finally, Crossmark Global Holdings Inc. raised its position in shares of Maximus by 9.8% in the third quarter. Crossmark Global Holdings Inc. now owns 4,152 shares of the health services provider's stock valued at $387,000 after buying an additional 369 shares in the last quarter. 97.21% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several analysts have recently issued reports on the company. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 target price on the stock in a report on Thursday, January 2nd. StockNews.com lowered shares of Maximus from a "buy" rating to a "hold" rating in a report on Friday, February 14th.

Remove Ads

Insider Activity at Maximus

In related news, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the transaction, the insider now directly owns 2,512 shares of the company's stock, valued at $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Bruce Caswell purchased 3,500 shares of the stock in a transaction on Tuesday, December 17th. The shares were purchased at an average price of $70.64 per share, with a total value of $247,240.00. Following the acquisition, the chief executive officer now owns 275,929 shares in the company, valued at approximately $19,491,624.56. The trade was a 1.28 % increase in their position. The disclosure for this purchase can be found here. 1.60% of the stock is currently owned by company insiders.

Maximus Price Performance

NYSE:MMS traded up $0.27 during trading hours on Thursday, hitting $66.80. The company's stock had a trading volume of 399,254 shares, compared to its average volume of 480,905. The company has a market capitalization of $3.78 billion, a P/E ratio of 14.37 and a beta of 0.71. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97. The stock has a fifty day simple moving average of $72.40 and a 200-day simple moving average of $79.74.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. On average, analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Saturday, February 15th were paid a $0.30 dividend. The ex-dividend date was Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.80%. Maximus's dividend payout ratio is 25.81%.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.